These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14976039)

  • 1. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.
    Milhem M; Mahmud N; Lavelle D; Araki H; DeSimone J; Saunthararajah Y; Hoffman R
    Blood; 2004 Jun; 103(11):4102-10. PubMed ID: 14976039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.
    Saraf S; Araki H; Petro B; Park Y; Taioli S; Yoshinaga KG; Koca E; Rondelli D; Mahmud N
    Transfusion; 2015 Apr; 55(4):864-74. PubMed ID: 25363624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.
    Shi J; Zhao Y; Ishii T; Hu W; Sozer S; Zhang W; Bruno E; Lindgren V; Xu M; Hoffman R
    Cancer Res; 2007 Jul; 67(13):6417-24. PubMed ID: 17616702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
    Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential.
    Araki H; Yoshinaga K; Boccuni P; Zhao Y; Hoffman R; Mahmud N
    Blood; 2007 Apr; 109(8):3570-8. PubMed ID: 17185465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
    Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
    Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.
    Araki H; Baluchamy S; Yoshinaga K; Petro B; Petiwala S; Parajuli R; Milhem M; Lavelle D; DeSimone J; Mahmud N
    Exp Hematol; 2009 Sep; 37(9):1084-95. PubMed ID: 19501128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.
    Araki H; Mahmud N; Milhem M; Nunez R; Xu M; Beam CA; Hoffman R
    Exp Hematol; 2006 Feb; 34(2):140-9. PubMed ID: 16459182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epigenetic reprogramming in hematopoietic stem cell function.
    Iancu-Rubin C; Hoffman R
    Curr Opin Hematol; 2015 Jul; 22(4):279-85. PubMed ID: 26049747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
    Shaker S; Bernstein M; Momparler LF; Momparler RL
    Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death.
    Koh SH; Choi HS; Park ES; Kang HJ; Ahn HS; Shin HY
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1039-45. PubMed ID: 15752760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction.
    Uchida N; Hsieh MM; Platner C; Saunthararajah Y; Tisdale JF
    PLoS One; 2014; 9(8):e104022. PubMed ID: 25089909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Hurtubise A; Momparler RL
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):618-25. PubMed ID: 16783580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.
    Giachelia M; D'Alò F; Fabiani E; Saulnier N; Di Ruscio A; Guidi F; Hohaus S; Voso MT; Leone G
    Leuk Res; 2011 Apr; 35(4):465-71. PubMed ID: 20869114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
    Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells.
    Bovenzi V; Momparler RL
    Cancer Chemother Pharmacol; 2001 Jul; 48(1):71-6. PubMed ID: 11488527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.
    Wang X; Zhang W; Ishii T; Sozer S; Wang J; Xu M; Hoffman R
    Cancer Res; 2009 Oct; 69(19):7612-8. PubMed ID: 19752087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.
    Coombes MM; Briggs KL; Bone JR; Clayman GL; El-Naggar AK; Dent SY
    Oncogene; 2003 Dec; 22(55):8902-11. PubMed ID: 14654786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A.
    Travers H; Spotswood HT; Moss PA; Turner BM
    Exp Cell Res; 2002 Nov; 280(2):149-58. PubMed ID: 12413881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.